Latest Insider Transactions at Molecular Templates, Inc. (MTEM)
This section provides a real-time view of insider transactions for Molecular Templates, Inc. (MTEM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Molecular Templates, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Molecular Templates, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 02
2024
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
250,000
+16.34%
|
$500,000
$2.35 P/Share
|
|
Apr 02
2024
|
Kevin M. Lalande |
BUY
Grant, award, or other acquisition
|
Indirect |
175,000
+50.0%
|
$350,000
$2.35 P/Share
|
|
Jul 17
2023
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
4,255,319
+21.6%
|
$0
$0.47 P/Share
|
|
Jul 07
2022
|
Jason S. Kim Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,089
+11.24%
|
$0
$0.71 P/Share
|
|
Jun 16
2022
|
Sean Mc Lennan Officer |
BUY
Open market or private purchase
|
Direct |
30,000
+50.0%
|
$0
$0.82 P/Share
|
|
Jun 15
2022
|
Shv Management Services, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
62,000
+21.83%
|
$0
$0.89 P/Share
|
|
Jun 15
2022
|
Kevin M. Lalande |
BUY
Open market or private purchase
|
Indirect |
62,000
+21.83%
|
$0
$0.89 P/Share
|
|
Jun 14
2022
|
Shv Management Services, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
60,000
+27.27%
|
$0
$0.87 P/Share
|
|
Jun 14
2022
|
Kevin M. Lalande |
BUY
Open market or private purchase
|
Indirect |
60,000
+27.27%
|
$0
$0.87 P/Share
|
|
Jun 13
2022
|
Shv Management Services, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,000
+50.0%
|
$0
$0.91 P/Share
|
|
Jun 13
2022
|
Kevin M. Lalande |
BUY
Open market or private purchase
|
Indirect |
100,000
+50.0%
|
$0
$0.91 P/Share
|
|
May 16
2022
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
200,000
+1.76%
|
$200,000
$1.18 P/Share
|
|
Apr 27
2022
|
Eric E Poma |
BUY
Exercise of conversion of derivative security
|
Direct |
34,156
+5.81%
|
$0
$0.71 P/Share
|
|
Jan 06
2022
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
200,000
+1.79%
|
$800,000
$4.04 P/Share
|
|
Sep 21
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
750,000
+6.5%
|
$4,500,000
$6.0 P/Share
|
|
Sep 16
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
100,000
+0.99%
|
$600,000
$6.13 P/Share
|
|
Jul 27
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
75,000
+0.75%
|
$525,000
$7.09 P/Share
|
|
Jul 26
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
80,000
+0.8%
|
$560,000
$7.0 P/Share
|
|
Jul 20
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
125,000
+1.26%
|
$875,000
$7.13 P/Share
|
|
Jul 19
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
119,382
+1.22%
|
$716,292
$6.96 P/Share
|
|
Jul 06
2021
|
Eric E Poma |
BUY
Exercise of conversion of derivative security
|
Direct |
3,563
+1.44%
|
$0
$0.71 P/Share
|
|
Jun 28
2021
|
Jason S. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,770
-3.21%
|
$22,160
$8.36 P/Share
|
|
Jun 28
2021
|
Jason S. Kim Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,038
+27.1%
|
$0
$0.71 P/Share
|
|
Apr 19
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
40,852
+0.43%
|
$326,816
$8.08 P/Share
|
|
Apr 15
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
150,000
+1.55%
|
$1,200,000
$8.62 P/Share
|
|
Apr 14
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
150,000
+1.58%
|
$1,200,000
$8.37 P/Share
|
|
Apr 13
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
100,000
+1.08%
|
$700,000
$7.81 P/Share
|
|
Apr 12
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
50,000
+0.55%
|
$400,000
$8.02 P/Share
|
|
Apr 09
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
235,664
+2.54%
|
$1,885,312
$8.23 P/Share
|
|
Apr 08
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
300,000
+3.29%
|
$2,400,000
$8.22 P/Share
|
|
Apr 07
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
200,000
+2.29%
|
$1,600,000
$8.24 P/Share
|
|
Apr 05
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
200,000
+2.35%
|
$1,800,000
$9.44 P/Share
|
|
Mar 29
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
80,000
+0.98%
|
$880,000
$11.45 P/Share
|
|
Feb 24
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
75,000
+0.92%
|
$825,000
$11.48 P/Share
|
|
Feb 23
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
235,004
+2.87%
|
$2,585,044
$11.29 P/Share
|
|
Feb 18
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
1,185,770
+13.31%
|
$14,229,240
$12.65 P/Share
|
|
Feb 01
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
80,000
+1.21%
|
$880,000
$11.69 P/Share
|
|
Jan 29
2021
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
80,000
+1.22%
|
$880,000
$11.94 P/Share
|
|
Dec 10
2020
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
320,000
+2.48%
|
$2,560,000
$8.29 P/Share
|
|
Dec 09
2020
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
125,000
+2.02%
|
$1,000,000
$8.62 P/Share
|
|
Nov 10
2020
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
80,000
+1.33%
|
$720,000
$9.16 P/Share
|
|
Nov 09
2020
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
80,000
+1.35%
|
$720,000
$9.05 P/Share
|
|
Nov 06
2020
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
470,335
+7.53%
|
$3,762,680
$8.33 P/Share
|
|
Nov 05
2020
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
75,000
+1.39%
|
$750,000
$10.86 P/Share
|
|
Oct 30
2020
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
80,000
+1.51%
|
$640,000
$8.83 P/Share
|
|
Oct 28
2020
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct |
80,000
+1.53%
|
$720,000
$9.4 P/Share
|
|
Nov 21
2019
|
Scott D Morenstein Director |
BUY
Open market or private purchase
|
Indirect |
468,750
+18.59%
|
$3,750,000
$8.0 P/Share
|
|
Dec 26
2018
|
Cdk Associates, L.L.C. Director |
BUY
Open market or private purchase
|
Direct |
25,000
+1.55%
|
$75,000
$3.45 P/Share
|
|
Sep 25
2018
|
Scott D Morenstein Director |
BUY
Open market or private purchase
|
Indirect |
545,454
+25.92%
|
$2,727,270
$5.5 P/Share
|